JMP Securities sets $19 target for Kalvista Pharmaceuticals stock
JMP Securities initiated coverage on Kalvista Pharmaceuticals Inc (NASDAQ: KALV), assigning a Market Outperform rating and setting a price target of $19.00. Currently trading at $8.77, the stock has ...
Gavin Newsom Notified of Intent to Recall as Petition Reaches Target
The petition received 105 signatures, and was sent to the California governor on Monday, Saving California Chairman Randy Economy told Newsweek.
Civil rights activists call for Target boycott after retailer backs away from diversity programs
Activists are calling for a nationwide boycott of Target following the company's decision to roll back its diversity, equity and inclusion initiatives.